Utility of Positron Emission Tomography Compared With Mediastinoscopy for Delineating Involved Lymph Nodes in Stage III Lung Cancer: Insights for Radiotherapy Planning From a Surgical Cohort

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 702-706

  Videtic, Gregory M M ^a   Rice, Thomas W ^a   Murthy, Sudish ^a   Suh, John H ^a   Saxton, Jerrold P ^a   Adelstein, David J ^a   Mekhail, Tarek M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Lung cancer; Mediastinoscopy; PET; Radiotherapy planning

Indexed keywords

BIOLOGICAL ORGANS; BODY FLUIDS; CRUDE PETROLEUM; DIAGNOSTIC RADIOGRAPHY; ELECTROTHERAPEUTICS; ENDOSCOPY; GOLD; HEALTH; IMAGING TECHNIQUES; MEDICAL IMAGING; PLASTIC BOTTLES; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; RADIOTHERAPY; STAGES; STANDARDS; THERMOGRAPHY (TEMPERATURE MEASUREMENT); TOMOGRAPHY; WINDOWS OPERATING SYSTEM;

CANCER PATIENTS; GOLD STANDARDS; LUNG CANCER; LYMPH NODES; MEDIASTINOSCOPY; NODAL SENSITIVITY; NON-SMALL-CELL LUNG CANCER; PET; POSITIVE PREDICTIVE VALUE; POSITRON EMISSION; POSITRON EMISSION TOMOGRAPHY (PET); RADIOTHERAPY PLANNING; STAGE III; STAGE III LUNG CANCER; TARGET DEFINITION;

POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINOSCOPY; NEOPLASM STAGING; PACLITAXEL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 52949098295     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.045     Document Type: Article

References (12)

1. Bucci M.K., Bevan A., and Roach III M. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 55 (2005) 117-1134
2. van Baardwijk A., Baumert B.G., Bosmans G., et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 32 (2006) 245-260
3. Rusch V.W. Mediastinoscopy: An endangered species?. J Clin Oncol 23 (2005) 8283-8285
4. DeCamp M.M., Rice T.W., Adelstein D.J., et al. Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J Thorac Cardiovasc Surg 26 (2003) 17-27
5. Lauer M.S., Murthy S.C., Blackstone E.H., et al. [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: Impact of verification bias. Arch Intern Med 167 (2007) 161-165
6. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis 127 (1983) 1
7. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
8. Rosenzweig K.E., Sura S., Jackson A., and Yorke E. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25 (2007) 5557-5561
9. Lauer M.S., Murthy S.C., Blackstone E.H., et al. [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: Impact of verification bias. Arch Intern Med 167 (2007) 161-165
10. Gupta N.C., Tamim W.J., Graeber G.G., et al. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 120 (2001) 521-527
11. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
12. Feigenberg S.J., Lango M., Nicolaou N., and Ridge J.A. Intensity-modulated radiotherapy for early larynx cancer: Is there a role?. Int J Radiat Oncol Biol Phys 68 (2007) 2-3